Does Sodium Sensitivity and Sodium Hypertension Cause Hyperaldosteronism?
No, sodium sensitivity and sodium-dependent hypertension do not cause hyperaldosteronism—the causality is reversed: hyperaldosteronism causes sodium-sensitive hypertension.
The Correct Causal Relationship
Primary aldosteronism is the underlying pathology that initiates salt-sensitive hypertension, not the other way around. The mechanism works as follows:
- Excess aldosterone production from autonomous adrenal secretion disrupts normal homeostatic feedback loops between sodium status and aldosterone levels 1
- This inappropriate aldosterone secretion for the sodium status creates the pathophysiologic environment where high salt intake drives blood pressure elevation
- The hypertension in primary aldosteronism is fundamentally salt-dependent because aldosterone's cardiovascular damage requires the presence of sodium—elevated aldosterone alone in sodium-deficient states does not cause cardiovascular damage 1
Hemodynamic Mechanism
Recent high-quality research definitively demonstrates how hyperaldosteronism initiates salt-sensitive hypertension:
Aldosterone promotes salt sensitivity by amplifying salt-induced increases in systemic vascular resistance (SVR) while simultaneously decreasing cardiac output 2. This 2023 study using continuous hemodynamic monitoring in aldosterone-infused rats showed that:
- Switching from low to high salt intake caused significantly greater increases in mean arterial pressure and SVR in aldosterone-treated versus control rats
- Heart rate and cardiac output actually decreased more in the aldosterone group
- This directly challenges the traditional view that hyperaldosteronism causes hypertension by increasing blood volume and cardiac output first 2
Glomerular Effects
Patients with primary aldosteronism demonstrate characteristic renal hemodynamic changes that reflect their sodium sensitivity:
- Sodium sensitivity is markedly elevated (0.111 ± 0.013 mmHg/mmol per day) 3
- Glomerular hyperfiltration (128 ml/min per 1.73 m²) and glomerular capillary hypertension (54 mmHg) are present 3
- These findings are typical of sodium-sensitive hypertension caused by enhanced tubular sodium reabsorption 3
Clinical Implications
The 2024 ESC Guidelines 4 and 2025 Endocrine Society Guidelines 5 emphasize that:
- Primary aldosteronism affects approximately 10% of hypertensive patients (with some evidence suggesting up to 30% may have relatively autonomous aldosterone secretion) 1, 6
- Screening should be performed in all hypertensive patients using aldosterone-to-renin ratio 5
- Sodium intake assessment (24-hour urinary sodium) is critical for interpreting screening results 4
Common Pitfall to Avoid
Do not confuse the presence of salt sensitivity in essential hypertension with primary aldosteronism. While some essential hypertensives show sodium sensitivity through altered renal vascular and adrenal responsiveness to angiotensin II 7, this represents a different pathophysiologic mechanism than the autonomous aldosterone hypersecretion seen in primary aldosteronism. The key distinguishing feature is that in primary aldosteronism, aldosterone levels are inappropriately elevated for the sodium status, whereas in essential hypertension with salt sensitivity, the renin-angiotensin-aldosterone system may show abnormal modulation but not autonomous hypersecretion 1.